ResourceClinical Diagnostics
The role of ESR1 mutations in breast cancer: Implications for diagnosis, treatment, and the development of companion diagnostics
25 Mar 2025ESR1 mutations fuel resistance to hormone therapy in HR+ metastatic breast cancer
ZeptoMetrix delves into the mechanisms and prevalence of ESR1 mutations in breast cancer, exploring their clinical implications and the role of companion diagnostics. It further highlights the essential role of robust controls in mutation detection assays to ensure precision and reliability, ultimately enhancing patient outcomes through personalized medicine. Ongoing research and innovation in ESR1 targeted therapies and diagnostic technologies is needed, as advancements in these fields can potentially transform breast cancer treatment.
Links
Tags
Clinical GeneticsMolecular Genetics covers the analysis of hereditary genetic disease and chromosomal abnormalities. Genetics can be analysed using DNA, RNA, and protein microarrays, PCR, RT PCR and DNA sequencing. Genetic equipment includes genetic workstations, thermal cyclers, cooling blocks and electrophoresis products. Diagnostic kits are used for DNA / RNA extraction and purification.Liquid BiopsiesLiquid biopsies are non-invasive tests used to detect cancer and other diseases by analyzing blood or other bodily fluids. This technique is gaining popularity for early detection, monitoring treatment response, and detecting minimal residual disease. Explore liquid biopsy solutions in our peer-reviewed product directory; compare products, check reviews, and get pricing directly from manufacturers.Breast CancerBreast cancer is a type of cancer that begins in the cells of the breast and can spread to other parts of the body. Early detection, accurate diagnosis, and targeted treatments are essential for improving patient outcomes. Browse our peer-reviewed product directory to find the best breast cancer research and diagnostic tools, compare products, check reviews, and get pricing directly from manufacturers.Cancer DiagnosticsThere are a wide variety of diagnostic tests for cancer available, and this range continues to expand as our knowledge of cancer improves. Current diagnostic methods include biopsy, imaging and blood tests for known biomarkers. New methods in research development include liquid biopsies and cancer breathalyzers.Companion DiagnosticsCompanion diagnostics are tests, often <i>in vitro</i>, that are used to determine whether a therapeutic product will be safe and effective for use on an individual. They also identify which patients will benefit most from them. Companion diagnostic tests are often developed in conjunction with the pharmaceutical industry.